Business
20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST
20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST.
About this update from Ehave Inc.
[{"type":"text","content":"\n MIAMI, Jan. 26, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) (the “Company”) announced today an upcoming complimentary Psychedelic Industry webinar for investors and interested individuals. The webinar is produced by PsyTech and titled “Progressive Applications of Ketamine - The Spearhead of Psychedelic Therapy.” Participants can expect a discussion on new approaches to ketamine-assisted treatment with the leading practitioners in the field. Participants will hear from the expert psychiatrists, anesthesiologists, and psychotherapists at the forefront of innovative – and highly impactful – therapeutic ketamine treatments. REGISTER NOW AT: https://psytechglobal.com/psytech-ketamine-roundtable/ The virtual investor webinar is open to individual investors, institutional investors, advisors, analysts and the Psychedelic Community. The program opens at 12:00 PM ET on Wednesday, January 27th. The webinar will be moderated by Mark Braunstein DO - Founder and CEO Reconscious Medical Speakers for the PsyTech Virtual Investor Conference include: Julane Andries, LMFT - Senior Psychotherapist Center for Transformational Psychotherapy Phil Wolfson MD - CEO Non-Profit Ketamine Research Foundation Steven L. Mandel MD - Founder & President Ketamine Clinics Los Angeles Abid Nazeer MD   Founder and President Aps Ketamine Casey A. Paleos MD -Science Director Mindbloom There are no fees to log-in, or attend the live presentations. REGISTER NOW AT: https://psytechglobal.com/psytech-ketamine-roundtable/ 20/20 Global through Mycotopia Therapies owns 10% of PsyTech. Ehave, Inc. (EHVVF) controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. Ehave will continue develop Ketadash, the Ehave Dashboard, its MegaTeam video game applications for children with ADHD, the safety and security of Electronic Health Records (EHRs), improving mental health, and combatting mental illness. About 20/20 Global and Mycotopia Therapy Mycotopia Therapy focuses on helping you heal and reclaim your life. Your journey of healing is an understanding of the causes and works to mental wellness through psychedelic enhanced psychotherapy, integrated with a professional team of mental wellness practit...